Institutional members access full text with Ovid®

Share this article on:

NEUROENDOCRINOLOGIC CONSIDERATIONS IN PARKINSON DISEASE AND OTHER MOVEMENT DISORDERS

Malaty, Irene A.; Lansang, M. Cecilia; Okun, Michael S.

CONTINUUM: Lifelong Learning in Neurology: April 2009 - Volume 15 - Issue 2, Neuroendocrinology - p 125-147
doi: 10.1212/01.CON.0000300028.61027.6f
Article

Multiple movement disorders have endocrinologic underpinnings, either as secondary consequences of a common underlying pathology or as a result of a true causative role. This chapter reviews the current knowledge about endocrinologic influences on movement disorders, including Parkinson disease, Huntington disease, Tourette syndrome, dystonia, restless legs syndrome, and a variety of other disorders. We will additionally discuss directions for future research.

Relationship Disclosure: Dr Malaty has nothing to disclose. Dr Lansang has received personal compensation for speaking engagements with Merck & Co, Inc., and sanofi-aventis. Dr Okun has received personal compensation from the Advanced Neuromodulation Systems, Inc., Medtronic, Inc., National Parkinson Foundation, NeuroPace, Inc., Neurotrax/COMPRESS, and Sabine Neurotechnology, Inc. Dr Okun owns stock in Sabine Neurotechnology, Inc., and is a founder of the COMPRESS software used for deep brain stimulation screening. Dr Okun receives or has received research grants from the Michael J. Fox Foundation for Parkinson's Research, the NIH, National Parkinson Foundation, and The Parkinson Alliance.

Unlabeled Use of Products/Investigational Use Disclosure: Drs Malaty, Lansang, and Okun have nothing to disclose.

© 2009 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website